Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas.
Feldman AL, Laurent C, Narbaitz M, Nakamura S, Chan WC, de Leval L, Gaulard P.
Virchows Arch. 2023 Jan;482(1):265-279. doi: 10.1007/s00428-022-03412-6. Epub 2022 Oct 10.
PMID:36210383
Celiac Disease Is a Risk Factor for Mature T and NK Cell Lymphoma: A Mendelian Randomization Study.
Martín-Masot R, Herrador-López M, Navas-López VM, Carmona FD, Nestares T, Bossini-Castillo L.
Int J Mol Sci. 2023 Apr 13;24(8):7216. doi: 10.3390/ijms24087216.
PMID:37108375
STAT3 Dysregulation in Mature T and NK Cell Lymphomas.
Seffens A, Herrera A, Tegla C, Buus TB, Hymes KB, Ødum N, Geskin LJ, Koralov SB.
Cancers (Basel). 2019 Nov 2;11(11):1711. doi: 10.3390/cancers11111711.
PMID:31684088
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study.
Bachy E, Savage KJ, Huang H, Kwong YL, Gritti G, Zhang Q, Liberati AM, Cao J, Yang H, Hao S, Hu J, Zhou K, Petrini M, Russo F, Zhang H, Sang W, Ji J, Ferreri AJM, Damaj GL, Liu H, Zhang W, Ke X, Ghiggi C, Huang S, Li X, Yao H, Paik J, Novotny W, Zhou W, Zhu H, Zinzani PL.
Blood Adv. 2023 Aug 22;7(16):4435-4447. doi: 10.1182/bloodadvances.2022009575.
PMID:37276067
Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas.
Bhansali RS, Barta SK.
Cancers (Basel). 2023 Feb 1;15(3):925. doi: 10.3390/cancers15030925.